‘Erox” (aka Pherin and Human Pheromone Sciences):
Not to be confused with Eros, as in The Scent of Eros products and the first book about human pheromones.
Despite what has been indicated in recent news news, I have seen no mention in the scientific literature of results from a unisex fragrance. Nothing indicates it might increase feelings of arousal, excitement, social warmth and friendliness. From the report/ad copy linked here, I can’t be sure if these results supposedly come from a study of the ER303 compound, and can’t assess the claim that it has been shown to increase feelings of attraction and flirtiness during a double blind placebo controlled study.
In contrast, results of a mixture of androsterone and androstenol were again presented in April 2011 at the annual meeting of the Association for Chemoreception Sciences. Our mixture, increases women’s observed flirtatious behavior and self-reported level of attraction during a 15 minute interaction with a man wearing the mixture.
I find it unfortunate that consumers appear to be in for another blast of product marketing geared to those who are desperate to believe in a magical aphrodisiacal effect (of sea coral?). At least, so far, there’s no claim that the new chemical acts via a non-functional organ or “sixth sense.” But that simply makes me wonder what their new approach will be.
My approach has been to detail the scientific facts we used in our study design that was the first to show behavioral affects of human pheromones. But our results have also been presented during different scientific congresses, so that they can be evaluated by peers, who are not as readily convinced by marketers when it comes to claims about their “pheromones”.
James V. Kohl detailedl how quantized energy-dependent microRNA biogenesis links the pheromone-controlled physiology of reproduction to biophysically constrained viral latency and healthy longevity. Links from what organisms eat to the enzyme-dependent metabolism of food also link metabolic networks to microRNA-mediated genetic networks in the context of RNA interference. Drug therapies alter RNA interference by altering cell type differentiation in all cells of all individuals of all species. For comparison, during the past 26 years, Kohl has detailed how the chemistry of protein folding is biophysically constrained at every level of biological organization by conserved molecular mechanisms.